NASDAQ:YI 111 (YI) Stock Price, News & Analysis $7.32 -0.06 (-0.81%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$7.35 +0.03 (+0.41%) As of 07/25/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About 111 Stock (NASDAQ:YI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get 111 alerts:Sign Up Key Stats Today's Range$7.14▼$7.3250-Day Range$6.93▼$8.3652-Week Range$4.14▼$12.60Volume5,780 shsAverage Volume8,899 shsMarket Capitalization$63.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview 111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China. Read More 111 Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks7th Percentile Overall ScoreYI MarketRank™: 111 scored higher than 7% of companies evaluated by MarketBeat, and ranked 917th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for 111. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of 111 is -11.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of 111 is -11.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about 111's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.27% of the float of 111 has been sold short.Short Interest Ratio / Days to Cover111 has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in 111 has recently increased by 11,577.78%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend Yield111 does not currently pay a dividend.Dividend Growth111 does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.27% of the float of 111 has been sold short.Short Interest Ratio / Days to Cover111 has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in 111 has recently increased by 11,577.78%, indicating that investor sentiment is decreasing significantly. News and Social Media2.4 / 5News Sentiment0.32 News Sentiment111 has a news sentiment score of 0.32. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.07 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for 111 this week, compared to 2 articles on an average week.Search Interest1 people have searched for YI on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, 111 insiders have not sold or bought any company stock.Percentage Held by Insiders43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 21.32% of the stock of 111 is held by institutions.Read more about 111's insider trading history. Receive YI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 111 and its competitors with MarketBeat's FREE daily newsletter. Email Address YI Stock News HeadlinesDriver headed to church clocked at 111 mph Sunday in Douglas CountyJuly 21, 2025 | msn.com'It's a miracle!' jokes world no. 111 Haotong Li on being solo 2nd at The OpenJuly 21, 2025 | msn.comI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.July 26 at 2:00 AM | Timothy Sykes (Ad)HARS: F-111, Mirage, Orion, Neptune | Museum TourJuly 21, 2025 | msn.comAgenda 111 projects at varied completion stages – ISSER clarifiesJuly 16, 2025 | msn.comMonsoon rains kill 111 as Indus river floods spread furtherJuly 16, 2025 | msn.comPakistan: 15 More Dead As Torrential Rain, Flash Floods Continue To Wreak Havoc; Death Toll Hits 111July 16, 2025 | msn.comDBR Bites #111: 5X5 And Man Alive...We’ve Got Hoops To Talk About!July 16, 2025 | msn.comSee More Headlines YI Stock Analysis - Frequently Asked Questions How have YI shares performed this year? 111's stock was trading at $6.23 at the beginning of the year. Since then, YI shares have increased by 17.5% and is now trading at $7.32. How were 111's earnings last quarter? 111, Inc. Sponsored ADR (NASDAQ:YI) released its earnings results on Thursday, June, 19th. The company reported ($0.20) EPS for the quarter. The business earned $486.35 million during the quarter. When did 111's stock split? Shares of 111 reverse split on the morning of Friday, January 24th 2025.The 1-10 reverse split was announced on Wednesday, January 8th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 23rd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did 111 IPO? 111 (YI) raised $140 million in an initial public offering on Wednesday, September 12th 2018. The company issued 9,300,000 shares at $14.00-$16.00 per share. J.P. Morgan, Citigroup and CICC acted as the underwriters for the IPO. How do I buy shares of 111? Shares of YI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of 111 own? Based on aggregate information from My MarketBeat watchlists, some other companies that 111 investors own include NVIDIA (NVDA), Teladoc Health (TDOC), Innovative Industrial Properties (IIPR), Magnite (MGNI), Roku (ROKU), Twilio (TWLO). Company Calendar Last Earnings6/19/2025Today7/26/2025Next Earnings (Estimated)8/27/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryRetail Current SymbolNASDAQ:YI CIK1738906 Webwww.111.com.cn Phone862120536666FaxN/AEmployees1,238Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.42 million Net Margins-0.48% Pretax Margin-0.17% Return on EquityN/A Return on Assets-2.45% Debt Debt-to-Equity RatioN/A Current Ratio1.14 Quick Ratio0.53 Sales & Book Value Annual Sales$1.97 billion Price / Sales0.03 Cash FlowN/A Price / Cash FlowN/A Book Value($10.43) per share Price / Book-0.70Miscellaneous Outstanding Shares8,640,000Free Float4,849,000Market Cap$63.24 million OptionableOptionable Beta0.44 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (NASDAQ:YI) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 111, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share 111 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.